
Atrial Fibrillation (AF) Ablation, specifically Pulmonary Vein Isolation (PVI), is a minimally invasive procedure designed to stop irregular heart rhythms by targeting the area where they most often begin: the pulmonary veins. In AFib patients, extra electrical signals (ectopic beats) originate from the muscle sleeves within these veins. By creating a barrier of scar tissue—which does not conduct electricity—abnormal signals are blocked from reaching the rest of the heart.
Paroxysmal (occasional) AFib that is symptomatic and not well-controlled by medication.
Persistent (continuous) AFib where restoring a normal rhythm would improve heart function.
Intolerance to anti-arrhythmic drugs or a desire to avoid long-term medication side effects.
Heart failure patients where AFib is significantly reducing the heart's pumping efficiency.
High-risk features where uncontrolled AFib could lead to heart enlargement or tachycardia-induced cardiomyopathy.
Radiofrequency (RF) Ablation: Using point-by-point heat energy to "cauterize" the tissue around the vein openings.
Cryoablation: A specialized balloon is inflated in the vein and uses extreme cold to freeze the tissue in a "single shot."
Pulsed Field Ablation (PFA): A newer, non-thermal method using ultra-rapid electrical fields to selectively target heart cells while sparing surrounding structures.
3D Electro-anatomical Mapping: Creating a "GPS-like" digital view of the heart's unique anatomy and electrical activity.
Transseptal Puncture: A controlled technique to reach the left atrium by crossing the wall between the heart's upper chambers.
Access: Catheters are inserted through the femoral vein in the groin and guided up to the heart under X-ray guidance.
Navigation: The doctor performs a transseptal puncture to move the catheters from the right atrium into the left atrium.
Mapping: A detailed 3D map identifies the pulmonary vein openings (ostia) and the source of triggers.
Ablation: Energy (Heat, Cold, or Electrical Fields) is applied to create a circumferential ring of scar tissue around each of the four pulmonary veins.
Verification: The clinical team checks that the veins are electrically disconnected ("acute isolation") before removing the catheters.
Fasting for 8–12 hours is required as the procedure is usually performed under general anesthesia.
Blood tests to check kidney function and ensure blood clotting levels are within a safe range.
Continuous use (or brief adjustment) of blood thinners (anticoagulants) as directed by the electrophysiologist.
A Transesophageal Echo (TEE) or CT scan is often performed right before the procedure to ensure no blood clots are in the heart.
Arranging for an overnight hospital stay and a support person for the recovery period.
Echocardiogram (TTE): To measure the size of the left atrium and evaluate overall heart valve and muscle function.
CT or MRI of the Heart: To provide a detailed anatomical map of the pulmonary veins for the 3D navigation system.
ECG and Holter Monitoring: To document the frequency and duration of AFib episodes.
Blood Tests: Comprehensive metabolic panel including thyroid function, as thyroid issues can trigger AFib.
Pulse Oximetry: To assess baseline oxygen levels and lung health.
Hospital Stay: Most patients stay overnight for observation and are discharged the next morning.
Initial Recovery: You must lie flat for 4–6 hours post-procedure; avoid heavy lifting and strenuous exercise for 5–7 days.
"Blanking Period": For the first 3 months, minor irregular beats are common while the scars fully form and inflammation subsides.
Medication: Blood thinners are typically continued for at least 3–6 months, even if the rhythm feels normal.
Follow-up: Regular rhythm monitoring (ECG or mobile monitors) to confirm long-term freedom from AFib.
High initial success: Over 95% achieve electrical isolation of the veins during the procedure.
Significantly improves quality of life by reducing or eliminating palpitations, fatigue, and shortness of breath.
Reduces the long-term risk of heart failure and stroke associated with uncontrolled AFib.
Often allows patients to reduce or stop potent anti-arrhythmic medications.
High success rates for paroxysmal AFib (70%–80% at one year) with modern 2026 techniques.